| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/04/2013 | US8455617 Melanocortin receptor-specific peptides |
| 06/04/2013 | US8455501 N-(5-cycloalkyl)-pyridin-3-yl carboxamides |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455479 Heterocyclic compounds |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8455432 Insulin sensitisers and methods of treatment |
| 06/04/2013 | US8455017 Active substance for improving hyperlipidemia and hypercholesterolemia |
| 06/04/2013 | CA2716449C Calcium carbonate granulation |
| 06/04/2013 | CA2512820C Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 06/04/2013 | CA2457801C Streptococcus thermophilus strain and use thereof |
| 05/30/2013 | WO2013078413A1 Modulators of lipid storage |
| 05/30/2013 | WO2013077553A1 Composition for alleviating hypoglycemia |
| 05/30/2013 | WO2013076471A1 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2013075391A1 Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| 05/30/2013 | WO2013075227A1 β-GLUCOCEREBROSIDASE CHAPERONES |
| 05/30/2013 | WO2013075172A1 Improved synergistic anti-diabetic compositions |
| 05/30/2013 | WO2013056245A3 Stearate compounds |
| 05/30/2013 | WO2013049365A3 Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives |
| 05/30/2013 | WO2013025073A3 Composition for preventing or treating diabetes complications containing quamoclit pennata extract |
| 05/30/2013 | WO2013011098A9 Imino-sugar c-glycosides, preparation and use thereof |
| 05/30/2013 | WO2012174478A9 Stable formulations of a hyaluronan-degrading enzyme |
| 05/30/2013 | WO2012140596A8 Glycoside derivatives and uses thereof |
| 05/30/2013 | CA2856102A1 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells |
| 05/30/2013 | CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | CA2854039A1 Isoxazole treatments for diabetes |
| 05/29/2013 | EP2597095A1 Fused heterocyclic compound and application thereof |
| 05/29/2013 | EP2597090A1 Crystalline dapagliflozin hydrate |
| 05/29/2013 | EP2596800A1 Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
| 05/29/2013 | EP2596786A1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| 05/29/2013 | EP2595988A1 Tricyclic compounds and methds of making and using same |
| 05/29/2013 | EP2595970A1 Derivatives of oxadiazole and pyridazine, their preparation and their application in therapeutics |
| 05/29/2013 | EP2595648A2 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | EP2395991B1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| 05/29/2013 | CN202950967U Carrier capsule containing materials of health care products |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN103124739A Novel glucagon like peptide analogs, composition, and method of use |
| 05/29/2013 | CN103124561A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 05/29/2013 | CN103121986A Crystal form E of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103120798A Preparation method and application of phospholipid complex with anti-oxidative stress |
| 05/29/2013 | CN103120767A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 05/29/2013 | CN103120732A Chinese medicinal composition for treating jaundice and preparation method thereof |
| 05/29/2013 | CN103120706A Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology |
| 05/29/2013 | CN103120695A Application of Gypensapogenin B in medicine for reducing blood sugar |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN103120654A Application of lanthanum acetate or hydrates for treating hyperphosphatemia |
| 05/29/2013 | CN103120636A Leg-slimming massage cream |
| 05/29/2013 | CN102558393B Preparation process of dalteparin sodium |
| 05/29/2013 | CN102552140B Liquid medicine composition of rosiglitazone |
| 05/29/2013 | CN102492594B Bamboo juice wine and preparation method thereof |
| 05/29/2013 | CN102415986B Insoluble medicament solid dispersion containing phosphatide and cholate and preparation method thereof |
| 05/29/2013 | CN102397287B Application of opuntia ficus-indica polysaccharide in preparation of medicine with hypolipidemic effect |
| 05/29/2013 | CN102397286B Application of prickly pear polysaccharide in preparation of medicament or health-care product with hypoglycemic effect |
| 05/29/2013 | CN102389386B Slimming cream |
| 05/29/2013 | CN102357212B Compound product obtained through supercritical CO2 extraction, and preparation method thereof |
| 05/29/2013 | CN102178733B Chinese medicinal preparation for treating diabetes and preparation method thereof |
| 05/29/2013 | CN102088988B Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 05/29/2013 | CN102018832B Weight-reducing composition and preparation method thereof |
| 05/29/2013 | CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same |
| 05/29/2013 | CN101889953B Device and method for manufacturing drug smoke liquid and drug smoke |
| 05/29/2013 | CN101791300B Acipimox push-pull osmotic pump controlled release tablet and preparation method thereof |
| 05/29/2013 | CN101669934B application of mango aglycone in preparing medicine for obesity |
| 05/29/2013 | CN101613266B Monohydroxy conjugated linoleic acid, preparation method and application thereof |
| 05/29/2013 | CN101553491B Quinoxaline derivative |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/28/2013 | US8450371 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/28/2013 | US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12. |
| 05/28/2013 | US8450331 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 05/28/2013 | CA2735184C Heteroaryls amide derivatives and their use as glucokinase activators |
| 05/28/2013 | CA2716352C Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2664113C Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 05/28/2013 | CA2648236C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/28/2013 | CA2623958C 2-heteroaryl-substituted indole derivative |
| 05/28/2013 | CA2598301C Salt of proline derivative, solvate thereof, and production method thereof |
| 05/28/2013 | CA2565630C Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2564592C Compositions for improving breast health in women |
| 05/28/2013 | CA2550625C Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2522708C Compositions for affecting weight loss |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2490452C .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2427661C Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/28/2013 | CA2423876C Novel selective bradykinin (bk) b1 peptidic receptor antagonists and uses thereof |
| 05/23/2013 | WO2013075117A2 Pegylated c-peptide |
| 05/23/2013 | WO2013074906A1 Compositions for controlling food intake and uses therefor |
| 05/23/2013 | WO2013074817A1 Solid state forms of linagliptin |
| 05/23/2013 | WO2013074641A1 Piperidinyl- substituted cyclic ureas as gpr119 modulators |
| 05/23/2013 | WO2013073775A1 Novel method for preparing metabolites of atorvastatin using bacterial cytochrome p450 and composition therefor |
| 05/23/2013 | WO2013073698A1 Cxcr4 activity inhibiting peptide and application thereof |
| 05/23/2013 | WO2013073620A1 Carotenoid-containing composition and method for producing same |
| 05/23/2013 | WO2013073483A1 Method for producing myo-inositol and myo-inositol derivative |
| 05/23/2013 | WO2013072767A1 Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture |
| 05/23/2013 | WO2013072522A1 Composition comprising chicory extract |